Intraprocedural activated clotting time and heparin dosage in pulsed field ablation of paroxysmal atrial fibrillation
Compared with RFCA, PFA was associated with longer intraprocedural ACTs, shorter initial ACTs, fewer initial ACTs in the therapeutic range, and longer times to achieve the target ACT.
Authors
- Chengming Ma (ORCID: https://orcid.org/0000-0001-6259-4455)
- Yunlong Xia (ORCID: https://orcid.org/0000-0003-4791-9666)
- Lianjun Gao (ORCID: https://orcid.org/0009-0007-7025-6801)
- Xianjie Xiao (ORCID: https://orcid.org/0009-0009-2577-4719)
- Shiyu Dai (ORCID: https://orcid.org/0000-0003-3171-4877)
- Wenwen Li (ORCID: https://orcid.org/0000-0001-9806-5045)
- Qian Chen (ORCID: https://orcid.org/0000-0002-9581-8002)
- Yuanjun Sun (ORCID: https://orcid.org/0000-0003-3490-2523)
- Xiaomeng Yin (ORCID: https://orcid.org/0000-0002-1359-7307)
- Zhongzhen Wang
Institutions
- Dalian Medical University (CN)
- First Affiliated Hospital of Dalian Medical University (CN)
Publication Details
- Journal
- Frontiers in Cardiovascular Medicine
- Published
- 2025-02-24
- DOI
- https://doi.org/10.3389/fcvm.2025.1501716
- Citations
- 3
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 4.16